tradingkey.logo

Cosmos Health Inc

COSM
查看詳細走勢圖
0.487USD
-0.020-3.96%
收盤 12/19, 16:00美東報價延遲15分鐘
15.52M總市值
虧損本益比TTM

Cosmos Health Inc

0.487
-0.020-3.96%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-3.96%

5天

+10.31%

1月

-21.92%

6月

+12.79%

今年開始到現在

-27.22%

1年

-16.47%

查看詳細走勢圖

TradingKey Cosmos Health Inc股票評分

單位: USD 更新時間: 2025-12-19

操作建議

Cosmos Health Inc當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在藥品行業排名124/158位。機構持股佔比非常高,近一個月多位分析師給出公司評級為。最高目標價3.00。中期看,股價處於下降通道。近一個月,市場表現非常差,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Cosmos Health Inc評分

相關信息

行業排名
124 / 158
全市場排名
404 / 4582
所屬行業
藥品

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 0 分析師
--
評級
3.000
目標均價
+511.87%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Cosmos Health Inc亮點

亮點風險
Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
業績增長期
公司處於發展階段,最新年度總收入54.43M美元
估值低估
公司最新PE估值-0.64,處於3年歷史低位
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉235.74K股
活躍度增加
近期活躍度增加,過去20天平均換手率0.15

Cosmos Health Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Cosmos Health Inc簡介

Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
公司代碼COSM
公司Cosmos Health Inc
CEOSiokas (Grigorios)
網址https://www.cosmosholdingsinc.com/

常見問題

Cosmos Health Inc(COSM)的當前股價是多少?

Cosmos Health Inc(COSM)的當前股價是 0.487。

Cosmos Health Inc 的股票代碼是什麼?

Cosmos Health Inc的股票代碼是COSM。

Cosmos Health Inc股票的52週最高點是多少?

Cosmos Health Inc股票的52週最高點是1.320。

Cosmos Health Inc股票的52週最低點是多少?

Cosmos Health Inc股票的52週最低點是0.280。

Cosmos Health Inc的市值是多少?

Cosmos Health Inc的市值是15.52M。

Cosmos Health Inc的淨利潤是多少?

Cosmos Health Inc的淨利潤為-22.38M。

現在Cosmos Health Inc(COSM)的股票是買入、持有還是賣出?

根據分析師評級,Cosmos Health Inc(COSM)的總體評級為--,目標價格為3.000。

Cosmos Health Inc(COSM)股票的每股收益(EPS TTM)是多少

Cosmos Health Inc(COSM)股票的每股收益(EPS TTM)是-0.760。
KeyAI